The preferred timing of treatment of nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) ...
Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...
An 82-year-old woman with a history of congestive heart failure was admitted to this hospital for volume overload. Ascites, ...
Recognizing that half of eligible children are not enrolled in the supplementary nutrition program for women, infants, and ...
A new FDA program is being promoted as a tool to facilitate the development and approval of therapies that are important for society. But it risks undermining regulatory innovation and trust in ...